国际眼科纵览 ›› 2013, Vol. 37 ›› Issue (3): 172-176.doi: 10 3760/ cma. j. issn.16735803 2013 03 007

• 综述 • 上一篇    下一篇

息肉状脉络膜血管病变的研究进展

王小琴  生侠  谢青   

  1. 570000 海南省海口市,中南大学湘雅医学院附属海口医院 海口市人民医院眼科
  • 收稿日期:2013-05-13 出版日期:2013-06-22 发布日期:2013-06-27
  • 通讯作者: 谢青,Email: doc_xq@163.com E-mail:doc_xq@163.com

Progressive research of polypoidal choroidal vasculopathy

WANG Xiao-qin, SHENG Xia, XIE Qing   

  1. Department of Ophthalmology, Haikou People's Hospital,   Xiangya  School of Medicine Affiliated Haikou Hospital,  Central South University, Haikou 570000,China
  • Received:2013-05-13 Online:2013-06-22 Published:2013-06-27
  • Contact: XIE Qing,Email: doc_xq@163.com E-mail:doc_xq@163.com

摘要: 息肉状脉络膜血管病变(polypoidal choroidal vasculopathy,PCV)与渗出型年龄相关性黄斑变性(agerelated macular degeneration, AMD)的临床表现十分相似,但PCV的流行病学特点、自然病程、影像学特征、预后均与渗出型AMD不同。临床上主要通过特异性眼底表现和吲哚青绿血管造影进行诊断及鉴别。目前PCV的病因、发病机制仍不清,治疗方法主要有激光光凝、光动力治疗、抗血管内皮生长因子药物治疗及联合治疗。

Abstract: The clinical manifestations of polypoidal choroidal vasculopathy (PCV) and exudative agerelated macular degeneration are very similar,but their epidemiology, natural course, imaging and prognosis are different. Diagnosis of PCV requires fundoscopic features and the imaging of indocyanine green angiography in clinic. The etiology and pathogenesis of PCV are still unknown.Its treatment mainly includes laser photocoagulation, photodynamic therapy, intravitreal antiVEGF drug and combination therapy.